Related Experiment Video
Updated: Aug 18, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Aortic stenosis: is it simply a degenerative process or an active atherosclerotic process?
Insights
Aortic stenosis, a common cause of valve replacement, shares risk factors with coronary artery disease. Treating these factors, like high cholesterol, may slow aortic stenosis progression.
Area of Science:
- Cardiology
- Vascular Biology
- Valvular Heart Disease
Background:
- Aortic stenosis is the leading cause of cardiac valve replacement globally.
- Age-related prevalence and shared risk factors with coronary artery disease (CAD) are noted.
- Calcium and lipid accumulation link CAD and aortic stenosis.
Discussion:
- Aggressive management of CAD risk factors, especially hyperlipidemia, may impact aortic stenosis progression.
- Review of current literature on vascular biology and aortic valve disease pathogenesis.
- Exploration of current and emerging treatment strategies for aortic stenosis.
Key Insights:
- Aortic stenosis progression may be influenced by managing shared risk factors with CAD.
- Understanding the link between vascular biology and aortic valve disease is crucial.
- Emerging therapies offer new hope for managing aortic stenosis.
Outlook:
- Further research into the pathobiology of aortic stenosis is warranted.
- Investigating the efficacy of lipid-lowering therapies in slowing aortic stenosis.
- Developing novel therapeutic targets for aortic valve disease.
Abstract:
Aortic stenosis remains the most common cause of cardiac valve replacement in developed countries. The prevalence of this condition increases with age, and many of the risk factors for coronary artery disease also appear related to the development and progression of aortic stenosis. Recent studies also suggest a relationship between calcium and lipid accumulation in both coronary artery disease and aortic stenosis. Most important, there is growing evidence that aggressive treatment of coronary artery disease risk factors, particularly hyperlipidemia, may influence the progression of aortic stenosis. In this article the current literature is reviewed as it relates to vascular biology, pathogenesis of aortic valve disease, and current and newly emerging management approaches in the care of the patient with aortic stenosis.
Related Concept Videos
Atherosclerosis I: Introduction
Aortic Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
